SLRN Kapitalisasi Akuntansi ACELYRIN

The market trend for Acelyrin, Inc. (SLRN) shares is fixed at 0.40. The company's supply stability is ensured by strict temperature control during the transportation of biologics to medical centers. The business relies on the creation of small proteins for the therapy of skin pathologies that overcome tissue barriers. However, a lack of sales and challenges with clinical trials have led to a partial investor exodus, and development is currently focused on patents under FDA supervision.

SLRN Kapitalisasi Buku ACELYRIN Inc. (21.02.2024 - 31.05.2025)

Rincian metrik lan analitis perusahaan ACELYRIN (SLRN)

- rega lan prakiraan konsensus rega:
Bagan owah-owahan rega ACELYRIN Inc.|SLRN - Bagan rega target
- data kapitalisasi pasar:
Kapitalisasi pasar Acelyrin Inc.|SLRN - Nilai Total Perusahaan
- data kapitalisasi buku:
Nilai Buku Saham ACELYRIN|SLRN - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku acelyrin.com|SLRN - Total Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Acelyrin, Inc.|SLRN - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Acelyrin Inc.|SLRN - Utang perusahaan|Utang marang nilai buku Acelyrin Inc.
Pambiji fundamental:SLRN - ACELYRIN Inc.

Book value reflects the total value of net assets, determining the fundamental stability of the business through the difference between all assets and liabilities. Analysis of the book equity chart allows for tracking the real growth of resources at Acelyrin, Inc. (SLRN), which is critical for assessing the investment efficiency in developing high-margin drugs for the treatment of autoimmune diseases.

Analisis pesaing Acelyrin, Inc.

HLN: Nilai Akuntansi Perusahaan|Nilai Buku Perusahaan Kenvue Inc.|VRNA (veronapharma.com) - Kapitalisasi Akuntansi|Nilai Buku Perusahaan Jyong Biotech MENS|Nilai Aset Bersih Ligand Pharmaceuticals Incorporated|Amneal Pharmaceuticals Inc (AMRX) - Kapitalisasi Buku|Nilai Akuntansi Perusahaan Perrigo Corp (PRGO)|Kapitalisasi Buku ALVO (Alvotech)|liquidia.com - Kapitalisasi Buku|Nilai Buku Perusahaan Galapagos (GLPG)|ANIP: Nilai Akuntansi Perusahaan|MNKD (MannKind Corp.) - Nilai Buku Perusahaan|Amphastar Corp (AMPH) - Aset Bersih Perusahaan|PCRX (Pacira BioSciences) - Kapitalisasi Buku|Kapitalisasi Buku ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan AQST (Aquestive Therapeutics Inc)|SCPH: Nilai Buku Perusahaan|TECX - Ekuitas Perusahaan|Aset Bersih Perusahaan Tonix Pharmaceuticals TNXP|SXTC - Total Aset Bersih|Kapitalisasi Buku eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Nilai Akuntansi Perusahaan|Kapitalisasi Buku EXOZ (Invizyne Technologies, Inc.)|Ekuitas Perusahaan ORMP|Entera Bio Ltd. (ENTX) - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan ipatherapeutics.com (HYFT)|Kapitalisasi Buku ABVC (ABVC BioPharma, Inc.)|Kapitalisasi Buku Cumberland Pharmaceuticals Inc CPIX|QNTM: Kapitalisasi Buku|FGEN - Aset Bersih Perusahaan|Kapitalisasi Buku TELO|RANI (Rani Therapeutics Holdings, Inc.) - Ekuitas Perusahaan|Nilai Buku Perusahaan Synergy CHC Corp.|Nilai Buku Perusahaan Rallybio Corp. (RLYB)|Lexaria Bioscience - Aset Bersih Perusahaan|Ekuitas Perusahaan PULM (Pulmatrix Corporation)|Nilai Buku Perusahaan Pheton Holdings|Nilai Akuntansi Perusahaan Aptorum Group Ltd APM|Kapitalisasi Buku LYRA (Lyra Therapeutics)|IBO: Pambiji Buku Bisnis|Nilai Buku Perusahaan tnfpharma.com|Kapitalisasi Akuntansi cbdMD|PRFX - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan Auris Medical|LIPO (Lipella Pharmaceuticals, Inc.) - Kapitalisasi Buku|Pambiji Buku Bisnis OPTN (OptiNose Inc)|PIRS - Nilai Buku Perusahaan|Kapitalisasi Akuntansi Procaps Group Corp PROC|PTPI: Kapitalisasi Buku|qlsyy.net (QLI) - Aset Bersih Perusahaan|TFF Pharmaceuticals, Inc. - Aset Bersih Perusahaan